Women's advocacy groups and research in breast cancer

被引:16
|
作者
Baum, M
Thornton, H
机构
[1] UCL, Dept Surg, London, England
[2] UCL, Dept Med Humanities, London, England
来源
BREAST | 2001年 / 10卷
关键词
D O I
10.1016/S0960-9776(16)30004-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper challenges women's advocacy groups to recognize their ethical obligation to promote the need for clinical research through programmes of public education. We identify 'informed consent' as the greatest obstacle to progress. Limitations to its achievement are described. The major tension in the doctor/patient relationship, which creates a clash of categorical imperatives for the clinician, is exacerbated by the current contemporary ethical model that the autonomy of the individual has dominance over individuals' involvement in the practice of evidence-based medicine for the good of society. Further obstacles of public suspicion, the anti-science lobby, financial recession and health services reforms are listed. Chance sighting of a 'Ladyplan' insurance scheme prompted a Lancet paper and editorial exploring ideas that women could insure themselves well by acquiring knowledge which would enable them to make informed decisions, should the need arise, thereby avoiding the trauma occasioned by ignorance of research methods. The development and working ethos of the Consumers' Advisory Group for Clinical Trials, built on exploration of the authors' vision of the potential of creating a working research partnership between health professionals and patients to break the impasse in progress., by sharing responsibility as joint owners, is described. This mutually educative mode of working led to identification of the duty of all beneficiaries of constantly improving outcomes, to work for society's enlightened understanding by campaigning to educate individuals while they are well from an early age. We advocate that discharge of societal responsibility, to begin to repay the debt for what has been euphemistically described as the 'social cost'. should be recognized by advocacy groups, by extending their activities into programmes of education to enlighten citizens, educating them about how they can redress the balance in their demands for rights. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:19 / 22
页数:4
相关论文
共 50 条
  • [21] Genetic testing for susceptibility to breast cancer: Findings from women's focus groups
    Tessaro, I
    Borstelmann, N
    Regan, K
    Rimer, BK
    Winer, E
    JOURNAL OF WOMENS HEALTH, 1997, 6 (03) : 317 - 327
  • [22] A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget
    Emma L Pennery
    Breast Cancer Research, 9
  • [23] Advocacy groups and the economic value of medical research
    Woolley, Mary
    NATURE, 2010, 466 (7302) : 28 - 28
  • [24] Advocacy groups and the economic value of medical research
    Mary Woolley
    Nature, 2010, 466 : 28 - 28
  • [25] A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget
    Pennery, Emma L.
    BREAST CANCER RESEARCH, 2007, 9 (Suppl 2):
  • [26] Advocacy Groups and Their Role in Rare Diseases Research
    Dunkle, Mary
    Pines, Wayne
    Saltonstall, Peter L.
    RARE DISEASES EPIDEMIOLOGY, 2010, 686 : 515 - 525
  • [27] YSC's research agenda on breast cancer in young women: what now?
    Merschdorf, J.
    Esser, M.
    Rowe, J.
    McCann, M.
    Lewis, S.
    BREAST, 2016, 29 : S12 - S12
  • [28] Breast Cancer and Women's Sexuality
    Katz, Anne
    AMERICAN JOURNAL OF NURSING, 2011, 111 (04) : 63 - 67
  • [29] Minority women and advocacy for women's health
    Kumanyika, SK
    Morssink, CB
    Nestle, M
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2001, 91 (09) : 1383 - 1388
  • [30] Decision aids for familial breast cancer: exploring women's views using focus groups
    Rapport, Frances
    Iredale, Rachel
    Jones, Wendy
    Sivell, Stephanie
    Edwards, Adrian
    Gray, Jonathon
    Elwyn, Glyn
    HEALTH EXPECTATIONS, 2006, 9 (03) : 232 - 244